Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prognostic significance of an invasive leader cell–derived mutation cluster on chromosome 16q

Cancer(2020)10.1002/cncr.32903Source: DataRank Database

Prognostic significance of an invasive leader cell–derived mutation cluster on chromosome 16q is a research paper published in Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

bioproject doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.33)OA: bronzeTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Manali Rupji ORCID,Bhakti Dwivedi ORCID,Jeanne Kowalski ORCID,Jessica Konen ORCID,Taofeek K. Owonikoko ORCID

Live enrichment

PubMed:32315457 PMC:PMC7275903 OpenAlex:https://openalex.org/W3017015269

National Cancer Institute

Grant: 1F31CA225049

National Cancer Institute

Grant: 1U54CA209992

National Cancer Institute

Grant: 2P30CA138292

National Cancer Institute

Grant: R01CA201340‐01

National Cancer Institute

Grant: R01CA236369

NCI NIH HHS

Grant: F31 CA225049

NCI NIH HHS

Grant: R01CA201340-01

NCI NIH HHS

Grant: P30 CA138292

NCI NIH HHS

Grant: R01 CA201340

NCI NIH HHS

Grant: R01 CA250422

NIGMS NIH HHS

Grant: T32 GM008169

NCI NIH HHS

Grant: U54 CA209992

FWCI

0.33

Citation Percentile

0.6%

Citation Trend

2019

2022

2023

2024

2025

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.32903

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.32903

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.32903

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32903

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncr.32903

Fields of Study

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Genomics and DiagnosticsAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Non-Small-Cell LungCell LineageChromosomes, Human, Pair 16FemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedMultigene FamilyMutationNeoplasm InvasivenessNeoplasm ProteinsProgression-Free SurvivalSequence Analysis, RNA

MeSH Terms

Progression-Free SurvivalAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungChromosomes, Human, Pair 16FemaleMultigene FamilyHumansMaleMiddle AgedMutationNeoplasm InvasivenessNeoplasm ProteinsBiomarkers, TumorGene Expression Regulation, NeoplasticSequence Analysis, RNACell Lineage

Keywords

AdenocarcinomaLung cancerMutationBiologyPhenotypeCancer researchOncologyMedicineMetastasisCancerGeneInternal medicineGeneticsHepatocellular carcinomaSurvivalMutationsLeader Cells

Sustainable Development Goals

SDG 0: No poverty